This Article Full Text (OnlineFirst PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by DeCarbo, W. T. PubMed Articles by DeCarbo, W. T. Social Bookmarking                         What's this?

Apligraf: Bilayered Skin Substitute to Augment Healing of Chronic Wounds in Diabetic Patients

^* To whom correspondence should be addressed. E-mail: wdecarbo{at}yahoo.com.

	Abstract

Chronic wounds are wounds that fail to heal or fail to progress to healing within an appropriate time frame. Standard wound care consists of debridement of all nonviable tissue, off-loading, and maintaining a moist environment, typically with saline-moistened gauze. Infection control, blood flow, and nutrition also play pivotal roles in wound healing. Bioengineered tissue, Apligraf, has been shown to be both efficacious and safe when used in chronic wounds. Apligraf delivers growth factors and cytokines to the wound environment to help complete closure and decrease healing time.

First published on November 2, 2009
Foot & Ankle Specialist 2009, doi:10.1177/1938640009354041


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?